KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Operating Expenses: 2009-2025

Historic Operating Expenses for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $177.6 million.

  • Charles River Laboratories International's Operating Expenses fell 10.85% to $177.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.6 million, marking a year-over-year decrease of 1.30%. This contributed to the annual value of $751.0 million for FY2024, which is 0.42% up from last year.
  • Per Charles River Laboratories International's latest filing, its Operating Expenses stood at $177.6 million for Q3 2025, which was down 7.29% from $191.5 million recorded in Q2 2025.
  • Charles River Laboratories International's Operating Expenses' 5-year high stood at $199.8 million during Q3 2023, with a 5-year trough of $131.7 million in Q2 2022.
  • Its 3-year average for Operating Expenses is $186.0 million, with a median of $186.3 million in 2024.
  • In the last 5 years, Charles River Laboratories International's Operating Expenses fell by 23.20% in 2022 and then skyrocketed by 51.66% in 2023.
  • Charles River Laboratories International's Operating Expenses (Quarterly) stood at $144.1 million in 2021, then surged by 38.53% to $199.6 million in 2022, then dropped by 1.25% to $197.1 million in 2023, then dropped by 0.73% to $195.7 million in 2024, then fell by 10.85% to $177.6 million in 2025.
  • Its last three reported values are $177.6 million in Q3 2025, $191.5 million for Q2 2025, and $177.8 million during Q1 2025.